HORIBA, a world chief in analytical and measurement expertise, has expanded its award-winning compact hematology instrument vary with the launch of latest fashions with Erythrocyte Sedimentation Charge (ESR) on board. The brand new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) now provide mixed testing for CBC/DIFF with ESR outcomes from complete blood in 60 seconds, including a complete profile for inflammatory illness evaluation to the devices’ already in depth performance.
Utilizing its hematology experience, HORIBA has developed the progressive “CoRA” (Correlated Rouleaux Evaluation) expertise to combine ESR into its three new analyzers. Combining full blood rely (CBC) and 5-population white blood cell differential (DIFF) with speedy ESR, calibrated to the Westergren reference technique, on one compact analyzer reduces prices per check and turnaround occasions, and saves laboratory area. This CoRA expertise is patented by HORIBA.
Each the Yumizen H550E and H500E fashions have been additional enhanced by providing new connectivity potentialities for information administration by HORIBA’s Yumizen P8000 middleware, together with Yumicare. This distant technical help instrument allows safe connection to the instrument to watch workload, reagent consumption, high quality management and instrument alarms.
In the course of the Yumizen H550 vary evolution, different key developments have included i-DoubleDiff applied sciences to boost velocity of diagnoses:
- “I” for Infectious screening: through the use of synthetic intelligence, the analyzer can show rating flags for infectious ailments akin to Malaria and Dengue Fever, making it a vital instrument in each superior and resource-limited healthcare settings.
- “DoubleDiff”: Regular leucocyte rely (Lymphocyte, Monocyte, Neutrophil, Eosinophil, Basophil) + Irregular leucocyte rely (IMG, IMM, IML, LIC, ALY). Requiring simply two reagents, this elevated analytical functionality from 27 to 37 parameters, supplies deeper insights and extra complete outcomes with oncology capabilities.
“Building on the global success of our previous Yumizen H550 range, we have designed the new analyzers to meet the increasing demand for affordable, robust, and highly capable hematology analyzers with connectivity that are suitable for any lab environment,” mentioned Arnaud Pradel, President, HORIBA ABX SAS. “It is one instrument with endless possibilities; and the capabilities of our Yumizen H550 range continue to grow to meet even more clinical lab needs.”
Because of its superior applied sciences, affordability, reliability and ease of use, the Yumizen H550 vary presents in depth functions in a wide range of scientific laboratory environments and scientific settings, together with: vital care, oncology care, infectious illness care, blood banks, satellite tv for pc laboratories and well being facilities.